lopinavir/ritonavir mylan
mylan pharmaceuticals limited - lopinavir, ritonavir - hiv infektioner - antivirale midler til systemisk anvendelse - lopinavir/ritonavir angives i kombination med andre antiretrovirale lægemidler til behandling af human immundefekt virus (hiv-1) inficeret voksne, unge og børn over 2 år. valget af lopinavir/ritonavir til at behandle proteasehæmmer oplevet hiv-1-inficerede patienter bør være baseret på individuelle viral resistens test og historie behandling af patienter.
flixotide 100 mikrogram/dosis inhalationspulver
glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 100 mikrogram/dosis
flixotide 250 mikrogram/dosis inhalationspulver
glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 250 mikrogram/dosis
flixotide 500 mikrogram/dosis inhalationspulver
glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 500 mikrogram/dosis
flixotide 500 mikrogram/dosis inhalationspulver
orifarm a/s - fluticasonpropionat - inhalationspulver - 500 mikrogram/dosis
flixotide 50 mikrogram/dosis inhalationspulver
glaxosmithkline pharma a/s - fluticasonpropionat - inhalationspulver - 50 mikrogram/dosis
flixotide 125 mikrogram/dosis inhalationsspray, suspension
glaxosmithkline pharma a/s - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis
flixotide 125 mikrogram/dosis inhalationsspray, suspension
orifarm a/s - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis
flixotide 125 mikrogram/dosis inhalationsspray, suspension
2care4 aps - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis
flixotide 125 mikrogram/dosis inhalationsspray, suspension
paranova danmark a/s - fluticasonpropionat - inhalationsspray, suspension - 125 mikrogram/dosis